Institutions / RA Capital Management, L.P. / Holdings

RA Capital Management, L.P.

All holdings · as of Mar 31, 2026

Company	Class	Value	Shares	% of portfolio
Palatin Technologies, Inc.PTN	Common Stock	$1.22M	70,000	0.0%
MAPLIGHT THERAPEUTICS INCMPLT	Common Stock	$5.05M	248,294	0.1%
MacroGenics, Inc.	—	$5.39M	1,864,176	0.1%
Werewolf Therapeutics, Inc.HOWL	Common Stock	$5.56M	6,681,307	0.1%
Equillium, Inc.	—	$6.19M	3,096,336	0.1%
Rani Therapeutics Holdings, Inc.	—	$6.25M	8,500,000	0.1%
Corvus Pharmaceuticals, Inc.	—	$6.58M	450,000	0.1%
NEWAMSTERDAM PHARMA CO NV-27	—	$6.68M	333,333	0.1%
Adicet Bio, Inc.	—	$8.05M	1,182,624	0.1%
Perceptive Capital Solutions Corp	—	$8.23M	750,000	0.1%
Avalo Therapeutics, Inc.	—	$9.90M	662,968	0.1%
Karyopharm Therapeutics Inc.	—	$10.68M	1,917,354	0.1%
Atrium Therapeutics, Inc.	—	$11.55M	864,102	0.1%
Acrivon Therapeutics, Inc.ACRV	Common Stock	$11.59M	8,340,508	0.1%
PALISADE BIO, INC.	—	$12.47M	7,124,116	0.1%
Helix Acquisition Corp. III	—	$12.70M	1,250,000	0.1%
Waystar Holding Corp.	—	$12.76M	529,400	0.1%
GeneDx Holdings Corp.	—	$13.48M	209,887	0.1%
Hinge Health, Inc.	—	$14.06M	364,613	0.1%
OnKure Therapeutics, Inc.	—	$16.55M	3,998,333	0.2%
Anteris Technologies Global Corp.	—	$16.65M	3,000,000	0.2%
Inspire Medical Systems, Inc.	—	$16.80M	325,663	0.2%
SAB Biotherapeutics, Inc.	—	$16.86M	4,401,500	0.2%
Contineum Therapeutics, Inc.	—	$16.93M	1,296,012	0.2%
Sutro Biopharma, Inc.	—	$17.82M	715,307	0.2%
BRIGHT MINDS BIOSCIENCES INC.	—	$19.34M	265,000	0.2%
Benitec Biopharma Inc.BNTC	Common Stock	$19.70M	1,850,000	0.2%
Relmada Therapeutics, Inc.	—	$20.51M	2,947,369	0.2%
C4 Therapeutics, Inc.CCCC	Common Stock	$21.04M	8,000,000	0.2%
GRAIL, Inc.	—	$22.13M	428,266	0.2%
Travere Therapeutics, Inc.	—	$22.19M	746,841	0.2%
Nkarta, Inc.NKTX	Common Stock	$22.80M	10,805,129	0.2%
Ovid Therapeutics Inc.	—	$23.79M	10,714,000	0.3%
Aclaris Therapeutics, Inc.	—	$25.52M	6,804,072	0.3%
ALX Oncology Holdings Inc.	—	$26.09M	13,011,849	0.3%
Aktis Oncology, Inc.AKTS	Common Stock	$26.89M	1,503,084	0.3%
Rezolute, Inc.	—	$28.00M	9,180,000	0.3%
ASSEMBLY BIOSCIENCES, INC.ASMB	Common Stock	$28.32M	1,020,410	0.3%
Lexeo Therapeutics, Inc.	—	$28.70M	5,000,000	0.3%
BioAge Labs, Inc.BIOA	Common Stock	$28.87M	1,650,648	0.3%
Mirum Pharmaceuticals, Inc.	—	$29.43M	318,554	0.3%
Design Therapeutics, Inc.DSGN	Common Stock	$31.63M	2,972,973	0.3%
PepGen Inc.	—	$35.51M	20,064,545	0.4%
Monopar Therapeutics Inc.MNPR	Common Stock	$36.56M	667,207	0.4%
LENZ Therapeutics, Inc.	—	$38.24M	4,178,823	0.4%
Olema Pharmaceuticals, Inc.	—	$38.77M	2,600,000	0.4%
Century Therapeutics, Inc.IPSC	Common Stock	$40.13M	17,754,430	0.4%
CAPRICOR THERAPEUTICS, INC.	—	$45.84M	1,507,844	0.5%
Fulcrum Therapeutics, Inc.	—	$46.43M	6,053,960	0.5%
4D MOLECULAR THERAPEUTICS, INC.	—	$47.01M	5,049,779	0.5%